Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles
The move comes as COVID vaccine makers grapple with pushback from the U.S. administration and weak U.S. demand for the shots.
Original Source
Read the full article at Japantimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.